Wednesday, July 8, 2026

pharma · Chronic Hepatitis B · Recurrent Genital Herpes Simplex Type 2 · ASMB

ASSEMBLY BIOSCIENCES

Assembly Biosciences is a pharma organization headquartered in South San Francisco, USA. It trades on NYSE under ticker ASMB. Primary therapeutic focus areas include Chronic Hepatitis B, Recurrent Genital Herpes Simplex

2 Tower Pl, 7th Floor, South San Francisco, California 94080, US HQ
2014 Founded
99 Employees
Public company Type
ASMB · NYSE Ticker
Company details
Status
Public
HQ
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US
Founded
2014
Employees
99
Programs
15
Drugs
10
Patents
14
Clinical program

VBR

Phase 2 · small molecule · Chronic Hepatitis B

VBR for Chronic Hepatitis B is a Phase 2 program (small_molecule) at ASSEMBLY BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).

← All ASSEMBLY BIOSCIENCES, INC. projects Phase 2 small molecule terminated

Internal code ABI-H0731-204

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
ASSEMBLY BIOSCIENCES, INC.
Phase
Phase 2
Modality
small_molecule
Indication
Chronic Hepatitis B
Status
terminated
Trials
1